Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mancuso

Showing results (141-150 of 219) with videos related to

Pageof 22
Sort By:
Biophysical Journal|November 5, 2015
Tomography of a Cryo-immobilized Yeast Cell Using Ptychographic Coherent X-Ray Diffractive ImagingK Giewekemeyer, C Hackenberg, A Aquila, et al.
Journal of Synchrotron Radiation|September 2, 2014
High-dynamic-range coherent diffractive imaging: ptychography using the mixed-mode pixel array detectorKlaus Giewekemeyer, Hugh T Philipp, Robin N Wilke, et al.
Diabetes, Obesity & Metabolism|December 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trialRichard E Pratley, Roy Eldor, Annaswamy Raji, et al.
Journal of Applied Crystallography|August 17, 2022
Towards real-time analysis of liquid jet alignment in serial femtosecond crystallographyJaydeep Patel, Adam Round, Johan Bielecki, et al.
Circulation|August 22, 2022
Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV TrialFrancesco Cosentino, Christopher P Cannon, Robert Frederich, et al.
Diabetes, Obesity & Metabolism|September 19, 2017
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized studySamuel Dagogo-Jack, Jie Liu, Roy Eldor, et al.
Mucosal Immunology|February 9, 2017
IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumoniaM A Kovach, B Singer, G Martinez-Colon, et al.
Leukemia & Lymphoma|August 20, 2005
Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromesA Cortelezzi, N S Fracchiolla, L Moronetti Mazzeo, et al.
Diabetologia|April 3, 2020
Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trialsDavid Z I Cherney, Hiddo J L Heerspink, Robert Frederich, et al.
Optics Express|August 10, 2017
Single-shot determination of focused FEL wave fields using iterative phase retrievalMasoud Mehrjoo, Klaus Giewekemeyer, Patrik Vagovič, et al.
Pageof 22

Showing results (141-150 of 219) with videos related to

Sort By:
Pageof 22
Biophysical Journal|November 5, 2015
Tomography of a Cryo-immobilized Yeast Cell Using Ptychographic Coherent X-Ray Diffractive ImagingK Giewekemeyer, C Hackenberg, A Aquila, et al.
Journal of Synchrotron Radiation|September 2, 2014
High-dynamic-range coherent diffractive imaging: ptychography using the mixed-mode pixel array detectorKlaus Giewekemeyer, Hugh T Philipp, Robin N Wilke, et al.
Diabetes, Obesity & Metabolism|December 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trialRichard E Pratley, Roy Eldor, Annaswamy Raji, et al.
Journal of Applied Crystallography|August 17, 2022
Towards real-time analysis of liquid jet alignment in serial femtosecond crystallographyJaydeep Patel, Adam Round, Johan Bielecki, et al.
Circulation|August 22, 2022
Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV TrialFrancesco Cosentino, Christopher P Cannon, Robert Frederich, et al.
Diabetes, Obesity & Metabolism|September 19, 2017
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized studySamuel Dagogo-Jack, Jie Liu, Roy Eldor, et al.
Mucosal Immunology|February 9, 2017
IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumoniaM A Kovach, B Singer, G Martinez-Colon, et al.
Leukemia & Lymphoma|August 20, 2005
Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromesA Cortelezzi, N S Fracchiolla, L Moronetti Mazzeo, et al.
Diabetologia|April 3, 2020
Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trialsDavid Z I Cherney, Hiddo J L Heerspink, Robert Frederich, et al.
Optics Express|August 10, 2017
Single-shot determination of focused FEL wave fields using iterative phase retrievalMasoud Mehrjoo, Klaus Giewekemeyer, Patrik Vagovič, et al.
Pageof 22